Zusammenfassung
Unter Dystonie versteht man langsame, unwillkürliche Kontraktionen vorwie gend der proximalen Muskulatur, die oft zu rotierenden Bewegungen und bizarren Gelenkstellungen sowie Körperpositionen führen. Die Dystönien werden nach Marsden (1982) unterteilt in: 1. fokale Dystönien, falls nur eine einzelne Region betroffen ist (z. B. Nacken oder Gesicht), 2. segmentale Dystönien, wenn ein Segment bilateral (z. B. beide Arme) oder wenn zwei oder drei benachbarte Körperabschnitte betroffen sind (z. B. Gesicht und Nacken) und 3. generalisierte Dystönien, falls ein Arm und Bein der jeweils anderen Seite oder mehr als drei Segmente betroffen sind (Fahn 1983). Aufgrund der symptomatischen Dystonien beim M. Wilson und Befunden bei perinatalen Schädigungen mit Dystonie wird eine Läsion der Basalganglien angenommen.
Eine frühere Fassung dieses Artikels findet sich in Brandt T, Dichgans J. und Diener H.C. (1987) Therapie und Verlauf neurologischer Erkrankungen. Kohlhammer, Stuttgart.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Literatur
Altrocchi PM (1972) Spontaneous oral-facial dsykinesia. Arch Neurol 28:506–512
Andrew J, Fowler CJ, Harrison MJG (1983) Stereotaxic thalamotomy in 55 cases of dys tonia. Brain 106:981–1000
Ansari KA, Webster D, Manning N (1972) Spasmodic torticollis and L-Dopa. Neurology 22:670–674
Asher SW, Aminoff MJ (1981) Tetrabenazine and movement disorders. Neurology 31:1051–1055
Barbeau A (1976) General discussion of drug therapy in dystonia. In: Elridge R, Fahn S (eds) Dystonia. Advances in Neurology, Vol 14. Raven, New York, pp 417–422
Bartels M, Zeller E (1984) Tetrabenazine (Nitoman) therapy of chronic spontaneous oral dyskinesia. A video-and EMG-controlled study. Eur Arch Psychiatr Neurol Sei 234:172–174
Bassi S, Ferrarese C, Frattola L, Sbacchi M, Trabucchi M (1982) Lisuride in generalized dys tonia and spasmodic torticollis. Lancet I: 514–515
Battista AF (1983) Surgical therapy for blepharospasm. In: Fahn S, Calne DB, Shoulson I (eds) Experimental therapeutics of movement disorders. Advances in Neurology, Vol 37. Raven, New York, pp 215–224
Bertrand C, Molina-Negro P, Bouvier G, Gorczyca W (1987) Observations and analysis of results in 131 cases of spasmodic torticollis after selective denervation. Appl Neurophysiol 50:319–323
Bird AC, McDonald WI (1975) Essential belpharospasm. Trans Ophthal Soc UK 95:250–253
Brennan MJW, Ruff P, Sandy KR (1982) Efficacy of a combination of sodium valproate and baclofen in Meige’s disease (idiopathic orofacial dystonia). Br Med J 285:853
Brinkmann A, Schumm F, Dichgans J (1985) Therapie des Meige-Syndroms. In: Gänshirt H, Berlit P, Haack G (Hrsg) Kardiovaskuläre Erkrankungen und Nervensystem -Neurotoxikologie -Probleme des Hirntodes. Verhandlungen der Deutschen Gesellschaft für Neurologie, Bd 3. Springer, Berlin Heidelberg New York Tokyo, S 662–666
Casey DE (1980) Pharmocology of blepharospasm oromandibular dystonia syndrome. Neurology 30:690–695
Cavenar JO, Brantley IJ, Braasch E (1978) Blepharospasm: Organic or funcitonal? Psychosomatics 19:623–628
Claus D, Aschoff JC (1979) Behandlung extrapyramidaler Bewegungsstörungen mitTiaprid. Arch Psychiat Nervenkr 227:151–158
Cleeland CS (1973) Behavioural technics in the modification of spasmodic torticollis. Neurology 23:1241–1247
Cooper IS (1976) 20-year follow-up study of the neurosurgical treatment of dystonia mus-culorum deformans. In: Elridge R, Fahn S (eds) Dystonia. Advances in Neurology, Vol 14. Raven, New York, pp 423–452
Couch JR (1976) Dystonia and tremor in spasmodic torticollis. In: Elridge R, Fahn S (eds) Dystonia. Advances in Neurology, Vol 14. Raven, New York, pp 245–258
Dahdaleh M, Small M, Thomas DJ (1975) Dimetyl aminoethanol in blepharospasm and hemifacial spasm. N Engl J Med 293:98
Delwaide PJ, Desseiles M (1977) Spontaneous buccolignofacial dyskinesia in the elderly. Acta Neurol Scand 56:256–262
Dowling-Bruun R (1984) Gilles de la Tourette’s syndrome. J Am Acad Child Psychiatry 23:126–133
Eldrigde R, Gottlieb R (1976) The primary hereditary dystonias: Genetic classification of 786 families and revised estimate of gene frequency, autosomal recessive form, and selected bibliography. Adv Neurol 14:457–474
Erenberg G, Cruse RP, Rothner AD (1987) The natural history of Tourette syndrome: A follow up study. Ann Neurol 22:383–385
Fahn S (1982) Torsion dystonia: Clinical spectrum and treatment. Sem Neurol 2:316:323
Fahn S (1983 a) High-dosage anticholinergic therapy in dystonia. In: Fahn S, Calne DB, Shoulson I (eds) Experimental therapeutics of movement disorders. Advances in Neurol ogy, Vol 37. Raven, New York, pp 177–188
Fahn S (1983 b) High dosage anticholinergic therapy in dystonia. Neurology 33:1255–1261
Foley J (1983) The athetoid syndrome. A review of a personal series. J Neurol Neurosurg Psychiatry 46:289–298
Frueh BR, Callahan A, Dortzbach RK, Wilkins RB, Beale HL, Reitman HS, Watson FR (1974) The effects of differential section of the Vllth nerve on patients with intractable blepharospasm. Trans Am Acad Ophthalmol Otolaryngol 81:595–602
Gautier JC, Awada A (1983) Dystonia musculorum deformans. Effet favorable de la bromocriptine. Rev Neurol 139:449–450
Geller M, Kaplan B, Christoff N (1976) Treatment of dystonic symptoms with carbamazepine. In: Elridge R, Fahn S (eds) Dystonia. Advances in Neurology, Vol 14. Raven, New York, pp 403–410
Gerber WD (1986) Neurologische Störungen. In: Miltner W, Bierbaumer N, Gerber WD (Hrsg) Verhaltensmedizin. Springer, Berlin Heidelberg New York Tokyo, S 386–428
Girotti F, Scigliano G, Nardocci N, Angelini L, Broggi G, Giovanni P, Caraceni T (1982) Idopathic dystonia: Neuropharmacological study. J Neurol 227:239–247
Gollomp SM, Fahn S, Burke RE, Reches A, Ilson J (1983) Therapeutic trials in Meige syndrome. In: Fahn S, Calne DB, Shoulson I (eds) Experimental therapeutics of movement disorders. Advances in Neurology, Vol 37. Raven, New York, pp 207–213
Goodwin-Austen RB, Clark T (1971) Persistent phenothiazine dyskinesia treated with tetrabenazine. Br Med J 4:25–26
Hagenah R, Habich C, Müller D (1983 a) Medikamentöse Therapie des Torticollis spasmodicus. Psycho 9:319–320
Hagenah R, Habich C, Müller D, Freckmann N (1983 b) Subjektive Beurteilung der Wirkung operativer Therapieverfahren beim Torticollis spasmodicus. Psycho 9:320–321
Henderson JW (1956) Essential blepharospasm. Trans Am Ophthalmol Soc 54:453–520
Houten R ten, Lakke JPWF, de Jong P, van Wesseling TW, van den Burg W, Wesseling H (1984) Spasmodic torticollis: Treatment with tizanidine. Acta Neurol Scand 70:373–376
Isgreen WP, Fahn S, Barrett RE, Snider SR, Chutorian AM (1976) Carbamazepine in torsion dystonia. In: Elridge R, Fahn S (Hrsg) Dystonia. Advances in Neurology, Vol 14. Raven, New York, pp 411–416
Jankovic J (1982) Treatment of hyperkinetic movement disorders with tetrabenazine: A double blind crossover study. Ann Neurol 11:41–47
Jankovic J. (1983) Tetrabenazine in the treatment of hyperkinetic movement disorders. In: Fahn S, Calne DB, Shoulson I (eds) Experimental therapeutics of movement disorders. Advances in Neurology, Vol 37. Raven, New York, pp 283–289
Jankovic J, Ford J (1983) Blepharospasm and orofacial-cervical dystonia: Clinical and pharmacological findings in 100 patients. Ann Neurol 13:402–411
Jayne D, Lees AJ, Stern GM (1984) Remission in spasmodic torticollis. J Neurol Neurosurg Psychiatry 47:1236–1237
Juntunen J, Kaste M, Ivanainen M, Ranta T, Seppälä M (1979) Bromocriptine treatment of spasmodic torticollis. Arch Neurol 36:449–450
Koller WC, Barr A, Biarry N (1982) Estrogen treatment of dyskinetic disorders. Neurology 32:547–549
Korein J, Brudny J, Grynbaum B, Sachs-Frankel G, Weisinger M, Levidow L (1976) Sensory feedback therapy of spasmodic torticollis and dystonia: Results in treatment of 55 pa tients. In: Elridge R, Fahn S (eds) Dystonia. Advances in Neurology, Vol 14. Raven, New York, pp 375–402
Korein J, Liebermann A, Kupersmith M, Levidow L (1981) Effect of L-glutamine and isoniazid on torticollis and segmental dystonia. Ann Neurol 10:247–250
Leiguarda RC, Pardal MF, Micheli F (1984) Reply from the author. Neurology 34:136
Leplow B, Lamparter U, Hagenah R (1983) Teilstationäre sensorische Feedbacktherapie des Torticollis spasmodicus. Psycho 9:312–321
Marinello C, Baumberger K, Fisch U (1979) Langzeitresultate der chirurgischen Therapie von Spasmus hemifacialis und Blepharospasmus. HNO 27:54–57
Marsden CD (1982) The focal dystonias. Sem Neurol 2:324–333
Marsden CD, Harrison MJG (1974) Idiopathic torsion dystonia. Brain 97:793–810
Marsden CD, Marion MH, Quinn N (1984) The treatment of severe dystonia in children and adults. J Neurol Neurosurg Psychiatry 47:166–1173
MesulamWM, Petersen RC (1987) Treatment of Gilles de laTourette syndrome. Neurology 37:1828–1833
Micheli F, Pardal MMF, Leiguarda RC (1982) Beneficial effects of lisuride in Meige disease. Neurology 32:432–434
Miller E (1973) Demethyl aminoethanol in the treatment of blepharospasm. N Engl J Med 289:697
Mitscherlich M (1983) Zur Theorie und Therapie des Torticollis. In: Studt HH (Hrsg) Psychosomatik in Forschung und Praxis. Urban & Schwarzenberg, München
Muenter MD, Gomez MR, Gordon H, Sharpless NS (1982) L-doparesponsive dystonia musculorum deformans with on-off effect. Neurology 32:A 112
Niewold JUR, Drentje B, Weerden TW, Lakke JPWF (1985) Biofeedback in the management of spasmodic torticollis. J Neurol 232 (Suppl):234
Nutt JG, Hammerstad JP, Carter JH, DeGarmo P (1983) Meigesyndrome: Treatment with trihexy-phenidyl. In: Fahn S, Calne DB, Shoulson I (eds) Experimental therapeutics of movement disorders. Advances in Neurology, Vol 37. Raven, New York, pp 201–205
Nutt JG, Hammerstad JP, DeGarmo P, Carter JH (1984) Cranial dystonia: Double-blind crossover study of anticholinergics. Neurology 34:215–217
Nutt JG, Hammerstad JP, Carter JH, DeGarmo PL (1985) Lisuride treatment of focal dystonias. Neurology 35:1242–1243
Obeso JA, Luquin MR (1984) Bromocriptine and lisuride in dystonias. Neurology 34:135
Pakkenberg H, Fog R (1974) Spontaneous oral dyskinesia. Arch Neurol 31:352–353
Paulson GW (1972) Meige’s syndrome. Dyskinesia of the eyelids and facial muscles. Geriatrics 27:69–73
Przuntek H, Monninger P (1983) Therapeutic aspects of kinesiogenic paroxysmal choreaathetosis and familial paroxysmal choreaathetosis of the Mount and Reback type. J Neurol 230:163–169
Quinn N, Marsden CD (1984) A double blind trial of sulpiride in Huntington’s disease and tardive dyskinesia. J Neurol Neurosurg Psychiatry 47:844–847
Regeur L, Pakkenberg B, Fog R, Pakkenberg H (1986) Clinical features and long-term treatment with pimozide in 65 patients with Gilles de la Tourette’s syndrome. J Neurol Neurosurg Psychiatry 49:791–795
Rentrop E, Straschill M (1982) Verlaufsformen des idiopathischen Torticollis spasmodicus. Aktuel Neurol 9:150–154
Richards CL, Bédard PJ, Fortin G, Malovin F (1983) Quantitative evaluation of the effects of L-dopa in torsion dystonia: A case report. Neurology 33:1083–1087
Schneider R, Buchan AP, Couston TA (1976) Low-dosage treatment withTetrabenazine. Br Med J I: 1212
Schumm F, Dichgans J, Zeller E (1981) Spontane orale dyskinesien. Erfolgreiche Therapie mit Tetrabenazin (Nitoman). Arch Psychiatr Nervenkr 230:315–323
Scott AB, Kennedy RA, Harrison AS (1985) Botulinum A toxin injection as a treatment for blepharospasm. Arch Ophthalmol (Chicago) 103:347–350
Shorr N, Seiff SR, Kopelman J (1985) The use of botulinum toxin in blepharospasm. Am J Ophthalmol 99:542–546
Singer K, Cheng MN (1971) Thiopropazate hydrochloride in persistent dyskinesia. Br Med J 4:22–25
Snoek JW, Weerden TW van, Teelken AW, Burg W van den, Lakke JP (1987) Meige syn drome: Double-blind crossover study of sodium valproate. J Neurol Neurosurg Psychiatry 50:1522–1525
Sörensen BF, Hamby WB (1966) Spasmodic torticollis. Results in 71 surgically treated patients. Neurology 16:867–878
Stahl SM, Berger PA (1971) Bromocriptine in dystonia. Lancet II: 745
Stahl SM, Berger PA (1982) Effects of bromocriptine and physostigmine in the dystonias. Neurology 32: A 112
Stahl SM, Yesavage JA, Berger PA (1982) Pharmacologic characteristics of Meige dystonia: Differentiation from tardive dyskinesia. J Clin Psychiatry 43:445–446
Stober T, Anstatt T, Schimrigk KK (1983) Erfolgreiche Isoniazid-Therapie bei athetotischem Syndrom. Nervenarzt 54:658–659
Swash M, Roberts AH, Zakko H, Heathfield KWG (1972( Treatment of involuntary movement disorder with tetrabenazine. J Neurol Neurosurg Psychiatry 35:186–191
Talbot JF, Gregor Z, Bird AC (1982) The surgical management of essential blepharospasm. In: Marsden CD, Fahn S (eds) Movement disorders. Butterworth, London, pp 322–329
Tanner CM, Glantz RH, Klawans HL (1981) Meige syndrome (blepharospasm oromandibular dystonia syndrome): Analysis of the clinical pharmacology in 12 patients. Neurology 31:78
Tanner CM, Glantz RH, Klawans HL (1982) Meige disease: Acute and chronic cholinergic effects. Neurology 32:783–785
Toglia JU, McGlamery M, Sambandham RR (1978) Tetrabenazine in the treatment of Huntingtons chorea and other hyperkinetic movement disorders. J Clin Psychiatry 39:81–87
Tolosa ES (1981) Clinical features of Meige’s disease (idiopathic orofacial dystonia). Arch Neurol 38:147–151
Tolosa ES, Lai CW (1979) Meige disease. Striatal dopaminergic preponderance. Neurology 29:1126–1130
Vizioli R, Dicerbo M, Vigliotti MR (1985) Familial paroxismal choreoathetosis. J Neurol 232 (Suppl) 235
Waltz JM, Davis JA (1983) Cervical cord stimulation in the treatment of athetosis and dystonia. In: Fahn S, Calne DB, Shoulson I (eds) Experimental therapeutics of movement disorders. Advances in Neurology, Vol 37. Raven, New York, pp 225–237
Weingarten CZ, Putterman AM (1976) The management of patients with essential blepharospasm. Eye Ear Nose Throat Monthly 55:8–24
Zeman W, Dyken P (1968) Dystonia musculorum deformans. In: Vinken PJ, Bruyn GW(eds) Diseases of the basal ganglia. Handbook of clinical neurology, Vol 6. North Holland Publ, Amsterdam, pp 517–543
Ziegler DK (1981) Prolonged relief of dystonic movements with diazepam. Neurology 31:1457–1458
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Dichgans, J., Brinkmann, A. (1989). Zur Therapie von Dystonien und Athetosen. In: Hippius, H., Rüther, E., Schmauss, M. (eds) Katatone und dyskinetische Syndrome. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-83654-1_13
Download citation
DOI: https://doi.org/10.1007/978-3-642-83654-1_13
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-50501-3
Online ISBN: 978-3-642-83654-1
eBook Packages: Springer Book Archive